The Oncology Institute, Inc. (TOI)

Market Cap	93.93M
Revenue (ttm)	393.41M
Net Income (ttm)	-53.01M
Shares Out	75.75M
EPS (ttm)	-0.71
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	903,492
Open	1.230
Previous Close	1.140
Day's Range	1.140 - 1.335
52-Week Range	0.125 - 1.630
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	May 13, 2025

About TOI

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplan...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2007
• Employees: 800
• Stock Exchange: NASDAQ
• Ticker Symbol: TOI
• Website: https://theoncologyinstitute.com

Financial Performance

In 2024, The Oncology Institute's revenue was $393.41 million, an increase of 21.33% compared to the previous year's $324.24 million. Losses were -$53.01 million, -21.91% less than in 2023.